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A novel Rab6-interacting domain defines a family of Golgi-targeted
coiled-coil proteins
Francis A. Barr
In recent years, a large number of coiled-coil proteins
localised to the Golgi apparatus have been identified
using antisera from human patients with a variety of
autoimmune conditions [1]. Because of their common
method of discovery and extensive regions of coiled-coil,
they have been classified as a family of proteins, the
golgins [1]. This family includes golgin-230/245/256,
golgin-97, GM130/golgin-95, golgin-160/MEA-2/GCP170,
giantin/macrogolgin and a related group of proteins —
possibly splice variants — GCP372 and GCP364 [2–11].
GM130 and giantin have been shown to function in the
p115-mediated docking of vesicles with Golgi cisternae
[12]. In this process, p115, another coiled-coil protein, is
though to bind to giantin on vesicles and to GM130 on
cisternae, thus acting as a tether holding the two
together [12,13]. Apart from giantin and GM130, none of
the golgins has yet been assigned a function in the Golgi
apparatus. In order to obtain clues as to the functions of
the golgins, the targeting to the Golgi apparatus of two
members of this family, golgin-230/245/256 and golgin-
97, was investigated. Each of these proteins was shown
to target to the Golgi apparatus through a carboxy-
terminal domain containing a conserved tyrosine
residue, which was critical for targeting. The domain
preferentially bound to Rab6 on protein blots, and
mutations that abolished Golgi targeting resulted in a
loss of this interaction. Sequence analysis revealed that
a family of coiled-coil proteins from mammals, worms
and yeast contain this domain at their carboxyl termini.
One of these proteins, yeast Imh1p, has previously been
shown to have a tight genetic interaction with Rab6 [14].
On the basis of these data, it is proposed that this family
of coiled-coil proteins functions in Rab6-regulated
membrane-tethering events.
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Results and discussion
Sequence analysis of the golgin-97 and golgin-230/245/256
clones present in the available databanks revealed the 
possibility that they are evolutionarily distantly related pro-
teins. The analysis was complicated by the fact that there
are a number of clones for golgin-230/245/256 that differ in
their amino- and carboxy-terminal regions, possibly indicat-
ing splice variation. Comparison of golgin-97 with golgin-
230/245/256 showed that these proteins have conserved
domains at both their amino termini (Figure 1a) and their
carboxyl termini (Figure 1b), in addition to having a central
coiled-coil domain. Because both proteins localise to the
Golgi complex, it is likely that one of the conserved
sequences is responsible for their correct subcellular target-
ing. To identify which of these sequences is important for
Golgi targeting, GFP-reporter proteins were constructed
using either the full-length proteins or the amino- and
carboxy-terminal domains of golgin-97. When GFP was
fused to the amino terminus of either full-length golgin-97
(Figure 2a) or full-length golgin-245 (Figure 2d), it was
found to localise to the Golgi apparatus, as defined by
control labelling with antibodies to GM130. In contrast, a
construct comprising the first 54 amino acids of golgin-97
fused to the amino terminus of full-length GFP did not
localise to the Golgi apparatus (Figure 2b). This result indi-
cated that the Golgi-targeting signal might lie in the con-
served carboxy-terminal domain. When the last 179 amino
acids of golgin-97 were fused to the carboxyl terminus of
full-length GFP (Figure 2c), the resulting fusion protein
was found to target to the Golgi apparatus, as defined by
the control labelling with antibodies to GM130.
Having identified the carboxy-terminal 179 amino acids of
golgin-97 as sufficient for Golgi targeting, this signal was
further defined using point mutagenesis of conserved
residues. Visual inspection of the sequence alignment
between the carboxyl termini of golgin-97 and golgin-
230/245/256 (Figure 1b) revealed two absolutely conserved
regions: ‘FEYL’, corresponding to amino acids 695–698;
and ‘MSW’, corresponding to amino acids 742–744 of
golgin-97. These residues were individually mutated to
alanine within the carboxy-terminal domain of golgin-97.
As above, the last 179 amino acids of golgin-97 (Figure 3a)
fused to GFP was found to target to the Golgi apparatus.
Only one residue was found to be absolutely required for
Golgi localisation, namely the conserved tyrosine residue
at position 697. Mutation of this residue, the Y697A muta-
tion (Figure 3d), completely abolished the Golgi targeting
of golgin-97. The F695A, E696A, L698A, M742A and
S743A point mutations (Figure 3b,c,e–g) had little or no
effect on the Golgi localisation of golgin-97. The W744A
point mutation (Figure 3h) had a marked effect on the tar-
geting of golgin-97 to the Golgi apparatus, relative to the
wild-type control (Figure 3a), but still allowed a significant
Golgi localisation. Mutation of the corresponding tyrosine
residue in golgin-245, Y2032A (Figure 3j), completely
abolished the Golgi localisation seen for wild-type golgin-
245 (Figure 3i). Therefore, the carboxy-terminal domain
present in golgin-97 and golgin-230/245/256 functions as a
tyrosine-based Golgi-targeting signal. 
Using this information, further sequence analysis of the
available databanks was performed. The results of this
analysis (Figure 1c) showed that there is a group of coiled-
coil proteins from yeast, worms and mammals with a
carboxy-terminal motif reminiscent of the domain found
in golgin-97 and golgin-230/245/256. These proteins all
have a tyrosine residue, marked by an asterisk in the align-
ment (Figure 1c), in the position defined by the mutagen-
esis of golgin-97. One of these proteins from budding
yeast, Imh1p, is known to be able to act as a suppressor of
ypt6 (yeast Rab6) mutations [13]. Rab6 is localised to the
Golgi apparatus in both yeast and mammalian cells, and
mutations in yeast Rab6 have been shown to result in a
defect in the maturation of carboxypeptidase Y, indicative
of a block in secretion [14]. In mammals, Rab6 has been
shown to interact with a kinesin-like motor protein and is
thought to regulate the directionality of membrane traffic
or membrane dynamics within the Golgi apparatus [15].
Given the genetic interaction between Rab6 and Imh1p, it
was decided to see whether Rab6 could be mediating the
binding of golgin-97 to the Golgi apparatus. To test for an
interaction between Rab6 and golgin-97, ‘farwestern’
protein blots were performed using recombinant Rabs 1,
2, 3a, 5, 6 and 11. Full-length golgin-97 gave a strong
signal with Rab6 but not with any of the other Rab pro-
teins tested (Figure 4a,b), indicating a specific interaction
with Rab6. Similar results were obtained for golgin-245,
which bound to Rab6 but not to Rab1. Full-length pro-
teins containing the point mutations used to define the
Golgi-targeting domain of golgin-97 were then used to
probe Rab6 farwesterns. The Y697A mutation completely
abolished binding to Rab6 on the farwestern, whereas the
F695A, E696A, L698A point mutations had no effect, and
the S743A and W744A point mutations caused some
reduction in binding to Rab6 (Figure 4c). Therefore, the
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Figure 1
A family of Golgi-localised coiled-coil proteins
that contain a conserved carboxy-terminal
sequence. (a) Alignment of the amino-terminal
domains of human golgin-256 (Hs GM256;
accession number X82834), human golgin-
230 (Hs GM230; accession number
U41740) and human golgin-97 (Hs GM97;
accession number U51587). (b) Alignment of
the carboxy-terminal domains of mouse
golgin-230 (Mm GM230; AF051357), human
golgin-245 (Hs GM245; U31906), and
human golgin-97 (Hs GM97; U51587).
(c) Alignment of a conserved domain present
in proteins of Schizosaccharomyces pombe
(Sp AC27D7.02c; AL009227),
Saccharomyces cerevisiae (Sc Imh1p;
U17247), Caenorhabditis elegans (Ce
T05G5.9; Z27079), mouse golgin-230 (Mm
GM230; AF051357), human golgin-97 (Hs
GM97; U51587), and human golgin-245 (Hs
GM245; U31906). The asterisk denotes the
conserved tyrosine residue. In (a—c), identical
residues are shaded grey and related residues
are shaded yellow.
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Figure 2
Targeting of golgin-97 and golgin-245 GFP-reporter proteins to the
Golgi apparatus. (a) Full-length golgin-97, (b) the amino-terminal 54
amino acids or (c) the carboxy-terminal 179 amino acids of golgin-97,
or (d) full-length golgin-245 were expressed as GFP-fusion proteins
in HeLa cells. Cells are shown after fixation and staining with an
antibody to GM130.
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carboxy-terminal domain of golgin-97 specifically binds to
Rab6 but not other Rabs on farwesterns through a con-
served tyrosine-based motif.
Analysis of the targeting of golgin-97 to the Golgi appara-
tus has led to the identification of a Rab6-interacting
domain. This domain defines a family of coiled-coil pro-
teins of unknown function from yeast, worms and
mammals that are targeted to the Golgi apparatus. One of
these proteins, yeast Imh1p,  has been shown to act as a
suppressor of yeast Rab6 mutations [14,16], supporting
the idea that this domain defines a family of Rab6-inter-
acting proteins. In one of these studies [16], the potential
interaction between Ypt6 and Imh1p was tested for by
yeast two-hybrid screening and a negative result was
obtained, although a known Ypt6-interacting protein,
Gyp6, gave a positive result. This difference from the
results presented here may indicate that the interaction
between Ypt6 and Imh1p is not amenable to study using
the yeast two-hybrid system, or may reflect differences in
the mammalian and yeast proteins. The small GTPases
Rab1 and Rab5 are thought to regulate docking events at
an early stage, and in both cases this event involves coiled-
coil proteins. There is evidence from yeast and mammals
that the coiled-coil proteins p115 (Uso1p in yeast), GM130
and giantin are important for the Rab1-regulated tethering
of endoplasmic reticulum to Golgi transport vesicles
[12–13]. Rab5-regulated endosome fusion involves EEA1,
Rabex-5 and Rabaptin-5, all of which contain coiled-coil
domains and interact directly or indirectly with Rab5
[17–20]. Interestingly, the region of Rabaptin-5 shown to
bind Rab5 has some similarities with the Rab6-binding
domain identified here — compare amino acids 820–862
(DFVKL to LPET) of Rabaptin-5 [20] with amino acids
695–738 (NFEYL to LKET) of golgin-97 (Figure 1b). On
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Figure 3
Analysis of the golgin-97 and golgin-245 targeting signals using 
GFP-reporter proteins and point mutagenesis. The carboxy-terminal
179 amino acids of (a) wild-type golgin-97, or of the (b) F695A,
(c) E696A, (d) Y697A, (e) L698A, (f) M742A, (g) S743A and
(h) W744A point mutants of golgin-97, or (i) wild-type golgin-245 and
(j) the Y2032A mutant of golgin-245 were expressed as GFP-fusion
proteins in HeLa cells. Cells are shown after fixation and staining with
an antibody to GM130.
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Interaction of golgin-97 and golgin-245 with Rab6 on farwestern blots.
Golgin-97 was used to probe farwestern blots of Rab1, 2, 3a, 5, 6 and
11. (a) A quantitation of such a blot is shown together with an
equivalent Coomassie-stained gel. (b) An autoradiograph of an
experiment using Rab1 and Rab6 probed with golgin-97 and
golgin-245. (c) To analyse the binding of the golgin-97 point mutants
to Rab6, farwesterns of Rab6 were probed with wild-type golgin-97
and full-length golgin-97 containing the carboxy-terminal point
mutations described in Figure 3. A typical autoradiograph of such a
blot is shown.
the basis of the data presented here, golgin-97 and pro-
teins possessing this Rab6-interacting domain are pro-
posed to function in membrane-tethering events in a
manner similar to that of the partners of Rab1 and Rab5.
The kinesin-like motor protein known to interact with
Rab6 [15] might function early in the tethering process to
bring the two membrane surfaces into position. Once posi-
tioned by the Rab6–kinesin complex, Rab6 might recruit
the golgin-97/230/245/256 family of proteins to tether the
two membranes to each other. Further work is needed to
define exactly what function proteins with this domain
have as Rab6 effectors. This domain has also been identi-
fied by Munro and Nichols and by Gleeson and colleagues
(this issue) and has been termed the ‘GRIP’ domain.
Materials and methods
Construction and expression of GFP-reporter constructs
Golgin-97 and golgin-245 were amplified from a human foetal and a
mouse liver Marathon cDNA library (Clontech), respectively. Point muta-
genesis of golgin-97 and golgin-245 was carried out using the
Quickchange method (Stratagene) and 33 bp primers designed to intro-
duce a codon for alanine at the desired position. Sequencing was used
to confirm all mutations. GFP-reporter constructs of the wild-type golgin-
97 carboxyl terminus and the forms containing point mutations were all
made using an XhoI–EcoRI fragment subcloned into pEGFP-C2 (Clon-
tech). Full-length golgin-97 and golgin-245 GFP-reporter constructs
were created using EcoRI fragments in pEGFP-C3 and pEGFP-C2,
respectively. HeLa cells were plated at 30% density on glass coverslips
in 2 cm wells, left to attach for 12 h, and then transfected using the
appropriate construct with Effectene (Qiagen). After 18 h, the cells were
fixed in methanol at –20°C and processed for immunofluorescence.
His6–GST fusion proteins and farwestern blotting
Human Rab6 was amplified from a foetal Marathon cDNA library (Clon-
tech). Clones for Rabs 3a, 5 and 11 were a gift from Sylvie Urbé. The
Rab1 and Rab2 clones were gifts from Hans Dieter Schmidt and
Marino Zerial, respectively. All Rab genes were cloned into pGAT2 to
create an amino-terminal fusion with the His6–GST tag present in this
vector. Fusion proteins were purified from bacterial lysates using
nickel–agarose chromatography. Farwestern blots were carried out as
described previously [12], using 2 µg of the required Rab fusion
protein as the target. The farwestern binding buffer was supplemented
with 10 µM GTPγS and the appropriate [35S]methionine-labelled
protein sample from one 50 µl in vitro translation reaction (Promega).
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